Position in PGEN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$12,966,345
+$3,879,306 QoQ
Shares Held
3,350,477
+54.1% QoQ
Ownership
0.940%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. PGEN ranks #124 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in PGEN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12,966,345 | 3,350,477 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,087,039 | 2,173,933 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $2,413,171 | 733,487 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $717,593 | 505,348 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $496,932 | 333,512 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $568,435 | 507,532 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $423,046 | 445,313 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $529,180 | 334,925 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $412,430 | 284,436 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $381,993 | 285,070 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $546,491 | 384,854 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $358,706 | 311,919 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $338,481 | 319,323 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $477,012 | 313,824 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $630,705 | 297,503 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $452,968 | 338,036 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $1,792,368 | 849,464 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,521,455 | 410,096 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $1,797,822 | 360,285 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $1,424,540 | 218,488 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $1,384,938 | 201,007 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,265,766 | 222,134 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,217,020 | 347,720 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,377,957 | 276,144 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,128,721 | 331,977 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||